Literature DB >> 15226563

Glucose-6-phosphate dehydrogenase deficiency in India.

Dipika Mohanty1, Malay B Mukherjee, Roshan B Colah.   

Abstract

Glucose-6-phosphate dehydrogenase (G6PD) deficiency is the commonest red cell enzymopathy in humans and has an X-linked inheritance. It has been reported from India more than 30 years ago and the prevalence varies from 0-27% in different caste, ethnic and linguistic groups. The major clinical manifestations are drug induced hemolytic anemia, neonatal jaundice and chronic non-spherocytic hemolytic anemia. Individuals with G6PD deficiency have a selective advantage against falciparum malaria. Thirteen biochemically characterized variants have been reported from India. At the molecular level, G6PD Mediterranean is the most common deficient variant in the caste groups whereas, G6PD Orissa is more prevalent among the tribal of India. The third common variant seen in India is G6PD Kerala-Kalyan.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15226563     DOI: 10.1007/bf02724295

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   1.967


  34 in total

1.  A rapid screening dye test for the detection of glucose-6-phosphate dehydrogenase deficiency in red cells.

Authors:  R E BERNSTEIN
Journal:  Nature       Date:  1962-04-14       Impact factor: 49.962

2.  G6PD Canton a common deficient variant in South East Asia caused by a 459 Arg----Leu mutation.

Authors:  D J Stevens; W Wanachiwanawin; P J Mason; T J Vulliamy; L Luzzatto
Journal:  Nucleic Acids Res       Date:  1990-12-11       Impact factor: 16.971

Review 3.  The molecular biology of G6PD variants and other red cell enzyme defects.

Authors:  E Beutler
Journal:  Annu Rev Med       Date:  1992       Impact factor: 13.739

4.  G6PD Kalyan and G6PD Kerala; two deficient variants in India caused by the same 317 Glu-->Lys mutation.

Authors:  A Ahluwalia; C M Corcoran; T J Vulliamy; C S Ishwad; J M Naidu; A Argusti; D J Stevens; P J Mason; L Luzzatto
Journal:  Hum Mol Genet       Date:  1992-06       Impact factor: 6.150

5.  Ascorbic-acid-induced haemolysis in G-6-PD deficiency.

Authors:  J B Mehta; S B Singhal; B C Mehta
Journal:  Lancet       Date:  1990-10-13       Impact factor: 79.321

Review 6.  Glucose-6-phosphate dehydrogenase deficiency in India and its clinical significance.

Authors:  S N Naik
Journal:  J Assoc Physicians India       Date:  1994-03

Review 7.  G6PD deficiency.

Authors:  E Beutler
Journal:  Blood       Date:  1994-12-01       Impact factor: 22.113

8.  Intravascular haemolysis and renal insufficiency in children with glucose-6-phosphate dehydrogenase deficiency, following antimalarial therapy.

Authors:  V P Choudhry; N Madan; S K Sood
Journal:  Indian J Med Res       Date:  1980-04       Impact factor: 2.375

9.  Three major G6PD-deficient polymorphic variants identified among the Mauritian population.

Authors:  R Kotea; J S Kaeda; S L Yan; N Sem Fa; S Beesoon; S Jankee; R Ramasawmy; T Vulliamy; R W Bradnock; J Bautista; L Luzzatto; R Krishnamoorthy; P J Mason
Journal:  Br J Haematol       Date:  1999-03       Impact factor: 6.998

10.  Glucose-6-phosphate dehydrogenase deficiency & neonatal hyperbilirubinaemia.

Authors:  N Madan; K R Sundaram; S K Bhargava; S K Sood
Journal:  Indian J Med Res       Date:  1989-08       Impact factor: 2.375

View more
  19 in total

1.  Intravascular haemolysis due to glucose-6-phosphate dehydrogenase deficiency in a patient with aluminium phosphide poisoning.

Authors:  R Srinivas; R Agarwal; A Jairam; V Sakhuja
Journal:  Emerg Med J       Date:  2007-01       Impact factor: 2.740

2.  Screening for G6PD Deficiency in Blood Donor Population.

Authors:  A M Shanthala Devi; Rose Helen; Alwar Vanamala; V Chaithra; Rameshkumar Karuna
Journal:  Indian J Hematol Blood Transfus       Date:  2010-10-19       Impact factor: 0.900

3.  Newborn screening for G6PD deficiency--why is it important for India?

Authors:  R Kishore Kumar; Nandini Nagar; Enzo Ranieri
Journal:  Indian J Pediatr       Date:  2013-04-19       Impact factor: 1.967

4.  Molecular Characterization of G6PD Deficiency: Report of Three Novel G6PD Variants.

Authors:  Arun Kumar Arunachalam; S Sumithra; Madhavi Maddali; N A Fouzia; Aby Abraham; Biju George; Eunice S Edison
Journal:  Indian J Hematol Blood Transfus       Date:  2019-10-16       Impact factor: 0.900

5.  Neonatal screening for glucose-6-phosphate dehydrogenase deficiency.

Authors:  Mritunjay Pao; Anjali Kulkarni; Vidya Gupta; Sushma Kaul; Saroja Balan
Journal:  Indian J Pediatr       Date:  2005-10       Impact factor: 1.967

Review 6.  Antimalarial drug policy in India: past, present & future.

Authors:  Anupkumar R Anvikar; Usha Arora; G S Sonal; Neelima Mishra; Bharatendu Shahi; Deepali Savargaonkar; Navin Kumar; Naman K Shah; Neena Valecha
Journal:  Indian J Med Res       Date:  2014-02       Impact factor: 2.375

7.  Causes of DMARD withdrawal following ADR within 6 months of initiation among Indian rheumatoid arthritis patients.

Authors:  Niti Mittal; Aman Sharma; Vinu Jose; Rakesh Mittal; Ajay Wanchu; Pradeep Bambery
Journal:  Rheumatol Int       Date:  2010-12-16       Impact factor: 2.631

8.  Structure and function of glucose-6-phosphate dehydrogenase-deficient variants in Chinese population.

Authors:  Weiying Jiang; Guolong Yu; Peng Liu; Qian Geng; Luming Chen; Qundi Lin; Xiaoqin Ren; Wenhong Ye; Yongshu He; Yibin Guo; Shan Duan; Jing Wen; Haiyuan Li; Yan Qi; Chengrui Jiang; Yongmei Zheng; Chun Liu; En Si; Qin Zhang; Qiuhong Tian; Chuanshu Du
Journal:  Hum Genet       Date:  2006-04-11       Impact factor: 4.132

9.  Red cell pyruvate kinase deficiency in neonatal jaundice cases in India.

Authors:  Prabhakar S Kedar; Prashant Warang; Roshan B Colah; Dipika Mohanty
Journal:  Indian J Pediatr       Date:  2006-11       Impact factor: 1.967

10.  Clinico-Haematological Profile of Hereditary Haemolytic Anaemias in a Tertiary Health Care Hospital in South India.

Authors:  Chaitra Venkataswamy; Am Shanthala Devi
Journal:  J Clin Diagn Res       Date:  2017-06-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.